Quality-of-Life Assessment for Cancer

Good Samaritan Hospital, West Islip, NY
CancerQuality-of-Life Assessment - Other
Eligibility
18+
All Sexes

Study Summary

This trial compares single-fraction SBRT to standard radiation therapy in treating metastatic cancer. SBRT uses special equipment to deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue.

Eligible Conditions
  • Metastatic Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 2

Similar Trials

1
Stereotactic ablative radiotherapy - De-escalation Level
1
45 Gray (Gy) regimen
1
Conventional EBRT

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Up to 12 weeks

Week 12
Change in Quality of life
Pain responses
Up to 12 weeks
Changes in immune markers
Cognitive function
Frailty Assessment
Hospitalization resulting from radiation treatment
Impact of the time of day of treatment on patient outcomes
Pain catastrophizing scale
Week 12
Overall survival

Trial Safety

Phase-Based Safety

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Stereotactic ablative radiotherapy - De-escalation Level
1
45 Gray (Gy) regimen
2
Conventional EBRT

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Arm II (SBRT)
1 of 2
Arm I (palliative RT)
1 of 2

Experimental Treatment

1500 Total Participants · 2 Treatment Groups

Primary Treatment: Quality-of-Life Assessment · No Placebo Group · Phase 2

Arm II (SBRT)Experimental Group · 3 Interventions: Questionnaire Administration, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy · Intervention Types: Other, Other, Radiation
Arm I (palliative RT)Experimental Group · 3 Interventions: Questionnaire Administration, Quality-of-Life Assessment, Palliative Radiation Therapy · Intervention Types: Other, Other, Radiation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Palliative Radiation Therapy
2015
Completed Phase 1
~20
Stereotactic Body Radiation Therapy
2019
Completed Phase 2
~800

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12 weeks

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
384 Previous Clinical Trials
28,369 Total Patients Enrolled
Anurag K SinghPrincipal InvestigatorRoswell Park Cancer Institute
5 Previous Clinical Trials
414 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have cancer that is causing symptoms or is likely to cause symptoms soon, and you may need radiation therapy to manage those symptoms.
References

Frequently Asked Questions

Is Quality-of-Life Assessment a reliable predictor of patient safety and health outcomes?

"Since this is a phase 2 trial, there is some evidence of safety but not efficacy. Therefore, our team scores Quality-of-Life Assessment as a 2." - Anonymous Online Contributor

Unverified Answer

Is there still room for new patients in this clinical trial?

"This research, which was initially published on November 18th 2019, is still recruiting patients according to information found on clinicaltrials.gov. The most recent update was made on May 2nd, 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top